UCI welcomes AMA's ban on glucocorticoids

The WADA has decided to ban glucocorticoids in competition as of January 1, 2022, a decision that has been welcomed "with satisfaction" by the UCI.

UCI-welcomes-AMA's-ban-on-glucocorticoids

The World Anti-Doping Agency (WADA) has decided to ban glucocorticoids in competition as of January 1, 2022, a decision that has been welcomed "with satisfaction" by the International Cycling Union (UCI). Glucocorticoids, hormones that are used to help the body resist stressful situations, will move away from sport and cycling, a fact that the president of the UCI, the Frenchman David Lappartient, has celebrated in a statement.

"The decision to generalize the prohibition of glucocorticoids in competition is another step in the protection of the health of athletes, especially cyclists, an issue that formed part of my campaign commitments in 2017 after the prohibition of tramadol in competition since 2019 and the implementation of a concussion management protocol in 2021, "said Lappartient. For the French leader it is "a new and important progress for the health of top-level athletes, a central theme of the 2022 Agenda" .

"I am pleased that the glucocorticoid ban falls within the competence of WADA. I would like to thank this decision which represents a breakthrough for sport in general and cycling in particular," explains David Lappartient in a UCI press release. All glucocorticoids administered, especially orally, intravenously and intramuscularly, are already banned in competition. However, this decision will also see the competitive ban, beginning in 2022, of periarticular, intraarticular, peritendinous, intratendinous, epidural, intrathecal, intrabursaal, intralesional, intradermal and subcutaneous injections.



Photos from as.com
Powered by Blogger.